| 000 | 01721 a2200445 4500 | ||
|---|---|---|---|
| 005 | 20250516120351.0 | ||
| 264 | 0 | _c20130129 | |
| 008 | 201301s 0 0 eng d | ||
| 022 | _a1090-0535 | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aSharma, Ajay | |
| 245 | 0 | 0 |
_aAttenuation of corneal myofibroblast development through nanoparticle-mediated soluble transforming growth factor-β type II receptor (sTGFβRII) gene transfer. _h[electronic resource] |
| 260 |
_bMolecular vision _c2012 |
||
| 300 |
_a2598-607 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S. | ||
| 650 | 0 | 4 |
_aActins _xbiosynthesis |
| 650 | 0 | 4 |
_aApoptosis _xdrug effects |
| 650 | 0 | 4 |
_aCell Survival _xdrug effects |
| 650 | 0 | 4 | _aCells, Cultured |
| 650 | 0 | 4 |
_aCornea _xdrug effects |
| 650 | 0 | 4 |
_aFibrosis _xchemically induced |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aImmunoglobulin Fc Fragments _xchemistry |
| 650 | 0 | 4 |
_aLipids _xchemistry |
| 650 | 0 | 4 |
_aMyofibroblasts _xdrug effects |
| 650 | 0 | 4 |
_aNanoparticles _xchemistry |
| 650 | 0 | 4 |
_aPlasmids _xchemistry |
| 650 | 0 | 4 |
_aPolyethyleneimine _xchemistry |
| 650 | 0 | 4 |
_aProtein Serine-Threonine Kinases _xchemistry |
| 650 | 0 | 4 | _aReceptor, Transforming Growth Factor-beta Type II |
| 650 | 0 | 4 |
_aReceptors, Transforming Growth Factor beta _xchemistry |
| 650 | 0 | 4 | _aSolubility |
| 650 | 0 | 4 |
_aTransfection _xmethods |
| 650 | 0 | 4 |
_aTransforming Growth Factor beta1 _xadverse effects |
| 700 | 1 | _aRodier, Jason T | |
| 700 | 1 | _aTandon, Ashish | |
| 700 | 1 | _aKlibanov, Alexander M | |
| 700 | 1 | _aMohan, Rajiv R | |
| 773 | 0 |
_tMolecular vision _gvol. 18 _gp. 2598-607 |
|
| 999 |
_c22226345 _d22226345 |
||